VEGFA and prostate cancer: In chondrosarcoma, a decrease in HDAC4 expression leads to the upregulation of vascular endothelial growth factor expression, thereby stimulating angiogenesis [42]; in prostate cancer cells, HDAC4 downregulation was associated with a high level of androgen receptor expression, which promoted cell growth [43].